1315 CAPITAL II, L.P. reported 1 transaction at INTERPACE BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/17/2026ACC: 0001493152-26-007093
10% Owner
Since Jan 2020
+9.39M
Net shares
Net buyer
$19.00M
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.41M acquired · 19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.41M
Price / share
$2.02
Trade value
$19M
% of position
New position
1/20/2026
0.00→9.41M
Total
Net shares
+9.41M
Net value
$19M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | C · Conversion | +9.41M | $2.02 | $19M | New position | 0.00 | 9.41M |
| Total | +9.41M | $19M | ||||||
Derivative Transactions1
Series C Convertible Preferred Stock
Direct
Converts to
Common Stock
9.41M shares
Shares
−19K
Strike price
2.02
Held after
0.00
Exercisable
—
1/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Convertible Preferred Stock Direct | Common Stock9.41M shares | 1/20/2026 | C · Conversion | −19K | 2.02 | — | 0.00 |